News Updates

September 17, 2019

The FDA’s presentation will provide a description of the IQOS heated tobacco products, a summary of the applications, the requirements of the Tobacco Control Act, FDA’s understanding of what it means to be “appropriate for the protection of public health,” and, finally, an explanation of the rationale for FDA’s decision regarding IQOS and how this may impact future Premarket Tobacco Applications and tobacco control.

July 6, 2019

The harm of smoking results mainly from long-term exposure to harmful and potentially harmful constituents (HPHCs) generated by tobacco combustion. Smoking cessation (SC) engenders favorable changes of clinical signs, pathomechanisms, and metabolic processes that together could reduce the harm of smoking-related diseases to a relative risk level approximating that of never-smokers over time. In most SC studies, the main focus is on the quitting rate of the SC program being tested. As there is limited information in the literature on short to multiple long-term functional or biological changes following SC, more data on short to mid-term favorable impacts of SC are needed.

July 5, 2019

A new study conducted by the American Cancer Society analyzed the changes in cigarette sales in Japan over the same period as heated-tobacco products (HTP) were launched. The results showed a significant decline in cigarette sales, beginning at the time of the introduction of PMI’s IQOS HTP. However, the combined sales of the HTP and cigarettes remained stable, indicating that the HTP replaced the cigarettes, rather than increasing overall tobacco consumption.

July 4, 2019

Philip Morris International (PMI) is welcoming applications to the new wave of its Postdoctoral Fellowship Program, scheduled to start in the autumn. Nine scientists are invited to apply for this unique opportunity, and the two-year program will be based in PMI’sstate-of-the-art Science & Innovation facility in Neuchâtel, Switzerland.

July 3, 2019

Cigarette smoking increases the risk of chronic diseases; heating instead of burning tobacco can lower these risks. This study (with 984 adult American smokers) examined whether favorable changes occur in eight co-primary endpoints (HDL-C; WBC; FEV1%pred; COHb; Total NNAL; sICAM-1; 11-DTX-B2; 8-epi-PGF2α) indicative of biological and functional effects when cigarette smokers switch to the heat-not-burn Tobacco Heating System 2.2 (THS).

July 1, 2019

Companies that fail to evolve are doomed to fail. But there are lessons to learn from those that adapted to the new environment that had changed around them.

July 1, 2019

Eight war veterans who have served in Afghanistan, Iraq, Bosnia and Kosovo have united for a once-in-a-lifetime experience at the home of Ferrari in Maranello, Italy. Two military veterans from the US and six from the UK, who experienced life-changing injuries as a result of their service, reached speeds of 160mph as they were driven around the marque’s famous Fiorano circuit by a professional racing driver in a specially designed three-seater Ferrari F1 car.

April 27, 2019

Despite the growing popularity of new alternatives to traditional tobacco products, there is still limited evidence on their indoor effect in particular in residential spaces as specific environments where enforcement of air quality standards is difficult. Hence, the impact of the Tobacco Heating System 2.2 (THS, marketed as IQOS®) on indoor air qualitywas assessed under controlled experimental conditions using ventilation representative of residential buildings with natural ventilation. Smoking of cigarettes (Marlboro Gold®) at the same ventilation conditions and consumption rates was used as positive control. Before each THS 2.2 or Marlboro Gold session, a background session with the same volunteers as for the product-use session was held.